Mammakarzinom bei älteren Patientinnen – Altersgerechte adjuvante systemische Therapie

Anne C. Regierer; Jan Eucker; Kurt Possinger

doi:10.1055/s-0031-1300976

Senologie - Zeitschrift für Mammadiagnostik und -therapie, Inhaltsverzeichnis

Senologie - Zeitschrift für Mammadiagnostik und -therapie 2011; 7(04): 175-178
DOI: 10.1055/s-0031-1300976

Aktuell diskutiert

Georg Thieme Verlag KG Stuttgart · New York

Mammakarzinom bei älteren Patientinnen – Altersgerechte adjuvante systemische Therapie

Anne C. Regierer

,

Jan Eucker

,

Kurt Possinger

Abstract

Volltext

Referenzen

Literatur
1 Molino A, Giovannini M, Auriemma A et al. Pathological, biological and clinical characteristics, and surgical management, of elderly women with breast cancer. Crit Rev Oncol Hematol 2006; 59: 226-233
2 Diab SG, Elledge RM, Clark GM. Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 2000; 92: 550-556
3 Gennari R, Curigliano G, Rotmensz N et al. Breast carcinoma in elderly women: Features of disease presentation, choice of local and systemic treatments compared with younger postmenopasual patients. Cancer 2004; 101: 1302-1310
4 Ma CD, Zhou Q, Nie XQ et al. Breast cancer in chinese elderly women: Pathological and clinical characteristics and factors influencing treatment patterns. Crit Rev Oncol Hematol 2009; 71: 258-265
5 Bouchardy C, Rapiti E, Fioretta G et al. Undertreatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol 2003; 21: 3580-3587
6 Yancik R, Wesley MN, Ries LA et al. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 2001; 285: 885-892
7 Hutchins LF, Unger JM, Crowley JJ, Coltman Jr CA, Albain KS. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999; 341: 2061-2067
8 Unger JM, Coltman Jr AA, Crowley JJ et al. Impact of the year 2000 medicare policy change on older patient enrollment to cancer clinical trials. J Clin Oncol 2006; 24: 141-144
9 Bouchardy C, Rapiti E, Blagojevic S, Vlastos AT, Vlastos G. Older female cancer patients: Importance, causes, and consequences of undertreatment. J Clin Oncol 2007; 25: 1858-1869
10 Hancke K, Denkinger MD, Koenig J et al. Standard treatment of female patients with breast cancer decreases substantially for women aged 70 years and older: A german clinical cohort study. Ann Oncol 2010; 21: 748-753
11 Giordano SH, Hortobagyi GN, Kau SW, Theriault RL, Bondy ML. Breast cancer treatment guidelines in older women. J Clin Oncol 2005; 23: 783-791
12 Giordano SH, Duan Z, Kuo YF, Hortobagyi GN, Goodwin JS. Use and outcomes of adjuvant chemotherapy in older women with breast cancer. J Clin Oncol 2006; 24: 2750-2756
13 Elkin EB, Hurria A, Mitra N, Schrag D, Panageas KS. Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: Assessing outcome in a population-based, observational cohort. J Clin Oncol 2006; 24: 2757-2764
14 Muss HH, Berry DA, Cirrincione CT et al. Adjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med 2009; 360: 2055-2065
15 Fargeot P, Bonneterre J, Roche H et al. Disease-free survival advantage of weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients: 6-year follow-up results of the french adjuvant study group 08 trial. J Clin Oncol 2004; 22: 4622-4630
16 Crivellari D, Bonetti M, Castiglione-Gertsch M et al. Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: The international breast cancer study group trial VII. J Clin Oncol 2000; 18: 1412-1422
17 Wildiers H, Paridaens R. Taxanes in elderly breast cancer patients. Cancer Treat Rev 2004; 30: 333-342
18 Du XL, Osborne C, Goodwin JS. Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer. J Clin Oncol 2002; 20: 4636-4642
19 Ibrahim NK, Buzdar AU, Asmar L, Theriault RL, Hortobagyi GN. Doxorubicin-based adjuvant chemotherapy in elderly breast cancer patients: The M. D. Anderson experience, with long-term follow-up. Ann Oncol 2000; 11: 1597-1601
20 Weggelaar I, Aben KK, Warle MC, Strobbe LJ, Spronsen DJ van. Declined guideline adherence in older breast cancer patients: A population-based study in the netherlands. Breast J 2011; 17: 239-245
21 Partridge AH, LaFountain A, Mayer E et al. Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. J Clin Oncol 2008; 26: 556-562
22 Ziller V, Kalder M, Albert US et al. Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer. Ann Oncol 2009; 20: 431-436
23 Crivellari D, Sun Z, Coates AS et al. Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: The big 1–98 trial. J Clin Oncol 2008; 26: 1972-1979